Rare Discordance Between DPYD HapB3 Markers Challenges Cancer Drug Phenotype Predictions
A study of 3,276 patients shows that rare biological discordance and technical misclassification between DPYD HapB3 variants can compromise pharmacogenetic ...
A study of 3,276 patients shows that rare biological discordance and technical misclassification between DPYD HapB3 variants can compromise pharmacogenetic ...
A study detailing two pediatric cases of dihydropyrimidine dehydrogenase deficiency reveals how identical genetic variants can manifest as drug-resistant epilepsy ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.